Randomized Phase III Trial of Sequential Chemoradiotherapy Compared With Concurrent Chemoradiotherapy in Locally Advanced Non???Small-Cell Lung Cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique???Groupe Fran??ais de Pneumo-Canc??rologie NPC 95-01 Study, Journal of Clinical Oncology, vol.23, issue.25, pp.5910-5917, 2005. ,
DOI : 10.1200/JCO.2005.03.070
Failure patterns in patients with esophageal cancer treated with definitive chemoradiation, Cancer, vol.76, issue.3 suppl 1, pp.2632-2672, 2012. ,
DOI : 10.1002/cncr.26586
A Review of Radiation Dose Escalation Trials for Non-Small Cell Lung Cancer Within the Radiation Therapy Oncology Group, Seminars in Oncology, vol.32, pp.111-113, 2005. ,
DOI : 10.1053/j.seminoncol.2005.03.020
Intrathoracic Patterns of Failure for Non???Small-Cell Lung Cancer??With Positron-Emission Tomography/Computed Tomography???Defined Target Delineation, International Journal of Radiation Oncology*Biology*Physics, vol.69, issue.5, pp.1409-1425, 2007. ,
DOI : 10.1016/j.ijrobp.2007.05.085
Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy 18Fluorodeoxyglucose-PET-CT scan, Radiotherapy and Oncology, vol.91, issue.3, pp.386-92, 2009. ,
DOI : 10.1016/j.radonc.2009.03.006
Identification of residual metabolic-active areas within NSCLC tumours using a pre-radiotherapy FDG-PET-CT scan: A prospective validation, Lung Cancer, vol.75, issue.1, pp.73-79, 2012. ,
DOI : 10.1016/j.lungcan.2011.06.003
Residual metabolic tumor activity after chemo-radiotherapy is mainly located in initially high FDG uptake areas in rectal cancer, Radiotherapy and Oncology, vol.99, issue.2, pp.137-178, 2011. ,
DOI : 10.1016/j.radonc.2011.04.004
Correlation of 18F-FDG Avid Volumes on Pre???Radiation Therapy and Post???Radiation Therapy FDG PET Scans in??Recurrent Lung Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.89, issue.1, pp.137-181, 2014. ,
DOI : 10.1016/j.ijrobp.2014.01.047
Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC), Radiotherapy and Oncology, vol.102, issue.2, pp.251-257, 2012. ,
DOI : 10.1016/j.radonc.2011.07.023
URL : https://hal.archives-ouvertes.fr/hal-00673355
FDG PET during radiochemotherapy is predictive of outcome at 1 year in non-small-cell lung cancer patients: a prospective multicentre study (RTEP2), European Journal of Nuclear Medicine and Molecular Imaging, vol.22, issue.2, pp.1057-65, 2014. ,
DOI : 10.1007/s00259-014-2687-9
Interobserver Agreement of Qualitative Analysis and Tumor Delineation of 18F-Fluoromisonidazole and 3'-Deoxy-3'-18F-Fluorothymidine PET Images in Lung Cancer, Journal of Nuclear Medicine, vol.54, issue.9, pp.1543-50, 2013. ,
DOI : 10.2967/jnumed.112.118083
Stability of 18F-Deoxyglucose Uptake Locations Within Tumor During Radiotherapy for NSCLC: A Prospective Study, International Journal of Radiation Oncology*Biology*Physics, vol.71, issue.5, pp.1402-1409, 2008. ,
DOI : 10.1016/j.ijrobp.2007.11.049
The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer, Radiotherapy and Oncology, vol.104, issue.1, pp.67-71, 2012. ,
DOI : 10.1016/j.radonc.2012.03.005
Pre-Chemoradiation Therapy FDG PET/CT Cannot Identify Residual Metabolically Active Areas in Patients With Locally Advanced Esophageal Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.84, issue.3, p.312, 2012. ,
DOI : 10.1016/j.ijrobp.2012.07.815
Survie attendue des patients atteints de cancers en france : état des lieux, Institut National du Cancer, p.18, 2010. ,
Intrathoracic Patterns of Failure for Non???Small-Cell Lung Cancer??With Positron-Emission Tomography/Computed Tomography???Defined Target Delineation, International Journal of Radiation Oncology*Biology*Physics, vol.69, issue.5, pp.1409-1425, 2007. ,
DOI : 10.1016/j.ijrobp.2007.05.085
Is pre-therapeutical FDG-PET/CT capable to detect high risk tumor subvolumes responsible for local failure in non-small cell lung cancer?, Radiotherapy and Oncology, vol.91, issue.3, pp.399-404, 2009. ,
DOI : 10.1016/j.radonc.2009.01.003
Identification of radioresistance: Validation of location residual metabolic-active areas. Molecular imaging of biologic characteristics and drug uptake, 2010. ,
Identification of residual metabolic-active areas within NSCLC tumours using a pre-radiotherapy FDG-PET-CT scan: A prospective validation, Lung Cancer, vol.75, issue.1, pp.73-76, 2012. ,
DOI : 10.1016/j.lungcan.2011.06.003
A planning study of radiotherapy dose escalation of PET-active tumour volumes in non-small cell lung cancer patients, Acta Oncologica, vol.70, issue.6, pp.883-891, 2011. ,
DOI : 10.3109/0284186X.2010.504735
The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer, Radiotherapy and Oncology, vol.104, issue.1, pp.67-71, 2012. ,
DOI : 10.1016/j.radonc.2012.03.005
Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC), Radiotherapy and Oncology, vol.102, issue.2, pp.251-257, 2012. ,
DOI : 10.1016/j.radonc.2011.07.023
URL : https://hal.archives-ouvertes.fr/hal-00673355
FDG PET during radiochemotherapy is predictive of outcome at 1 year in non-small-cell lung cancer patients: a prospective multicentre study (RTEP2), European Journal of Nuclear Medicine and Molecular Imaging, vol.22, issue.2, 2014. ,
DOI : 10.1007/s00259-014-2687-9
Interobserver Agreement of Qualitative Analysis and Tumor Delineation of 18F-Fluoromisonidazole and 3'-Deoxy-3'-18F-Fluorothymidine PET Images in Lung Cancer, Journal of Nuclear Medicine, vol.54, issue.9, pp.1543-50, 2013. ,
DOI : 10.2967/jnumed.112.118083
Block Matching: A??General??Framework??to??Improve Robustness of??Rigid??Registration of Medical Images, MICCAI LNCS 1935, pp.557-566, 2000. ,
DOI : 10.1007/978-3-540-40899-4_57
URL : https://hal.archives-ouvertes.fr/inria-00615860
Interreader Agreement and Variability of FDG PET Volumetric Parameters in Human Solid Tumors, American Journal of Roentgenology, vol.202, issue.2, pp.406-418, 2014. ,
DOI : 10.2214/AJR.13.10841
Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding, Cancer, vol.34, issue.S12, pp.2505-2514, 1997. ,
DOI : 10.1002/(SICI)1097-0142(19971215)80:12+<2505::AID-CNCR24>3.0.CO;2-F
Are More Aggressive Therapies Able to Improve Treatment of Locally Advanced Non-Small Cell Lung Cancer: Combined Modality Treatment?, Seminars in Oncology, vol.32, pp.25-34, 2005. ,
DOI : 10.1053/j.seminoncol.2005.03.007
Prediction of residual metabolic activity after treatment in NSCLC patients, Acta Oncologica, vol.29, issue.2, pp.1033-1042, 2010. ,
DOI : 10.1016/S0167-8140(99)00087-0
F]Fluorodeoxyglucose Positron Emission Tomography in Patients With Locally Advanced Non???Small-Cell Lung Cancer Undergoing Definitive Chemoradiation Therapy: Results of the ACRIN 6668/RTOG 0235 Trial, Journal of Clinical Oncology, vol.31, issue.30, pp.3823-3853, 2013. ,
DOI : 10.1200/JCO.2012.47.5947
Stability of 18F-Deoxyglucose Uptake Locations Within Tumor During Radiotherapy for NSCLC: A Prospective Study, International Journal of Radiation Oncology*Biology*Physics, vol.71, issue.5, pp.1402-1409, 2008. ,
DOI : 10.1016/j.ijrobp.2007.11.049
A Phase I/II Radiation Dose Escalation Study With Concurrent Chemotherapy for Patients With Inoperable Stages I to III Non-Small-Cell Lung Cancer: Phase I Results of RTOG 0117, International Journal of Radiation Oncology*Biology*Physics, vol.77, issue.2, pp.367-372, 2010. ,
DOI : 10.1016/j.ijrobp.2009.04.029
A Randomized Phase III Comparison of Standard-Dose (60 Gy) Versus High-dose (74 Gy) Conformal Chemoradiotherapy +/-Cetuximab for Stage IIIA/IIIB Non-Small Cell Lung Cancer: Preliminary Findings on Radiation Dose in RTOG 0617 [late-breaking abstract], ASTRO, p.201, 2011. ,
A randomized phase III comparison of standard-dose (60 Gy) versus high-dose (74 Gy) conformal chemoradiotherapy with or without cetuximab for stage III non-small cell lung cancer: Results on radiation dose in RTOG 0617, J Clin Oncol, issue.15, p.317501, 2013. ,
Hypoxia and tumor metabolism in radiation oncology: targets visualized by positron emission tomography, Q J Nucl Med Mol Imaging, vol.57, issue.3, pp.244-56, 2013. ,
Biological significance of 18F-FDG uptake on PET in patients with non-small-cell lung cancer, Lung Cancer, vol.83, issue.2, pp.197-204, 2014. ,
DOI : 10.1016/j.lungcan.2013.11.025
The Warburg Effect: Why and How Do Cancer Cells Activate Glycolysis in the Presence of Oxygen? Anti-Cancer Agents in Medicinal Chemistry-Anti-Cancer Agents), pp.305-317, 2008. ,
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation, Science, vol.324, issue.5930, pp.1029-1062, 2009. ,
DOI : 10.1126/science.1160809
Why do cancers have high aerobic glycolysis? Nat Rev Cancer, pp.891-900, 2004. ,
Transcription Factor HIF-1 Is a Necessary Mediator of the Pasteur Effect in Mammalian Cells, Molecular and Cellular Biology, vol.21, issue.10, pp.3436-3480, 2001. ,
DOI : 10.1128/MCB.21.10.3436-3444.2001
Pharmacologic activation of tumor hypoxia: a means to increase tumor 2-deoxy-2-[18F]fluoro-D-glucose uptake? Mol Imaging, pp.49-58, 2013. ,
The maximum uptake of 18F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1?? and GLUT-1 in non-small cell lung cancer, European Journal of Cancer, vol.43, issue.9, pp.1392-1400, 2007. ,
DOI : 10.1016/j.ejca.2007.03.027
A challenge to traditional radiation oncology, International Journal of Radiation Oncology*Biology*Physics, vol.60, issue.4, pp.1241-56, 2004. ,
DOI : 10.1016/j.ijrobp.2004.07.691
Oesophageal carcinoma, The Lancet, vol.381, issue.9864, pp.400-412, 2013. ,
DOI : 10.1016/S0140-6736(12)60643-6
Radiotherapy versus surgery within multimodality protocols for esophageal cancer ??? A meta-analysis of the randomized trials, Cancer Treatment Reviews, vol.38, issue.6, pp.599-604, 2012. ,
DOI : 10.1016/j.ctrv.2011.10.005
Chemoradiation Followed by Surgery Compared With Chemoradiation Alone in Squamous Cancer of the Esophagus: FFCD 9102, Journal of Clinical Oncology, vol.25, issue.10, pp.1160-1168, 2007. ,
DOI : 10.1200/JCO.2005.04.7118
URL : https://hal.archives-ouvertes.fr/hal-00363743
Esophageal carcinoma advances in treatment results for locally advanced disease: review, Annals of Oncology, vol.23, issue.5, pp.1095-103, 2012. ,
DOI : 10.1093/annonc/mdr433
INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III Trial of Combined-Modality Therapy for Esophageal Cancer: High-Dose Versus Standard-Dose Radiation Therapy, Journal of Clinical Oncology, vol.20, issue.5, pp.1167-74, 2002. ,
DOI : 10.1200/JCO.2002.20.5.1167
Induction cisplatin???irinotecan followed by concurrent cisplatin???irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial, British Journal of Cancer, vol.88, issue.6, pp.705-714, 2006. ,
DOI : 10.1038/sj.bjc.6690233
Failure patterns in patients with esophageal cancer treated with definitive chemoradiation, Cancer, vol.76, issue.3 suppl 1, pp.2632-2672, 2012. ,
DOI : 10.1002/cncr.26586
Esophageal Cancer Dose Escalation Using a Simultaneous Integrated Boost Technique, International Journal of Radiation Oncology*Biology*Physics, vol.82, issue.1, pp.468-74, 2012. ,
DOI : 10.1016/j.ijrobp.2010.10.023
Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer, Radiotherapy and Oncology, vol.77, issue.3, pp.247-53, 2005. ,
DOI : 10.1016/j.radonc.2005.10.017
Comparison of conformal and intensity-modulated techniques for simultaneous integrated boost radiotherapy of upper esophageal carcinoma, World J. Gastroenterol. WJG, vol.10, pp.1098-102, 2004. ,
Comparison of Heart and Coronary Artery Doses Associated With Intensity-Modulated Radiotherapy Versus Three-Dimensional Conformal Radiotherapy for Distal Esophageal Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.83, issue.5, pp.1580-1586, 2012. ,
DOI : 10.1016/j.ijrobp.2011.10.053
Dosimetric comparison of helical tomotherapy, RapidArc, and a novel IMRT & Arc technique for esophageal carcinoma, Radiotherapy and Oncology, vol.101, issue.3, pp.431-438, 2011. ,
DOI : 10.1016/j.radonc.2011.08.030
Inverse planning in three-dimensional conformal and intensity-modulated radiotherapy of mid-thoracic oesophageal cancer, The British Journal of Radiology, vol.77, issue.919, pp.568-72, 2004. ,
DOI : 10.1259/bjr/19972578
Intensity-Modulated Proton Therapy Further Reduces Normal Tissue Exposure During Definitive Therapy for Locally Advanced Distal Esophageal Tumors: A Dosimetric Study, International Journal of Radiation Oncology*Biology*Physics, vol.81, issue.5, pp.1336-1378, 2011. ,
DOI : 10.1016/j.ijrobp.2010.07.2001
18F-FDG PET/CT Has a High Impact on Patient Management and Provides Powerful Prognostic Stratification in the Primary Staging of Esophageal Cancer: A Prospective Study with Mature Survival Data, Journal of Nuclear Medicine, vol.53, issue.6, pp.864-71, 2012. ,
DOI : 10.2967/jnumed.111.101568
F-Fluorodeoxyglucose Positron Emission Tomography in Esophageal Cancer, Journal of Clinical Oncology, vol.22, issue.18 ,
DOI : 10.1200/JCO.2004.01.083
Clinical evidence on PET-CT for radiation therapy planning in gastro-intestinal tumors, Radiotherapy and Oncology, vol.96, issue.3, pp.339-385, 2010. ,
DOI : 10.1016/j.radonc.2010.07.019
GTV spatial conformity between different delineation methods by 18FDG PET/CT and pathology in esophageal cancer, Radiotherapy and Oncology, vol.93, issue.3, pp.441-447, 2009. ,
DOI : 10.1016/j.radonc.2009.07.003
Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy 18Fluorodeoxyglucose-PET-CT scan, Radiotherapy and Oncology, vol.91, issue.3, pp.386-92, 2009. ,
DOI : 10.1016/j.radonc.2009.03.006
Identification of residual metabolic-active areas within NSCLC tumours using a pre-radiotherapy FDG-PET-CT scan: A prospective validation, Lung Cancer, vol.75, issue.1, pp.73-79, 2012. ,
DOI : 10.1016/j.lungcan.2011.06.003
Residual metabolic tumor activity after chemo-radiotherapy is mainly located in initially high FDG uptake areas in rectal cancer, Radiotherapy and Oncology, vol.99, issue.2, pp.137-178, 2011. ,
DOI : 10.1016/j.radonc.2011.04.004
Combined Chemotherapy and Radiotherapy Compared with Radiotherapy Alone in Patients with Cancer of the Esophagus, New England Journal of Medicine, vol.326, issue.24, pp.1593-1601, 1992. ,
DOI : 10.1056/NEJM199206113262403
Interreader Agreement and Variability of FDG PET Volumetric Parameters in Human Solid Tumors, American Journal of Roentgenology, vol.202, issue.2, pp.406-418, 2014. ,
DOI : 10.2214/AJR.13.10841
18F-fluorodeoxyglucose positron emission tomography after definitive chemoradiotherapy in patients with oesophageal carcinoma, Digestive and Liver Disease, vol.44, issue.10, pp.875-884, 2012. ,
DOI : 10.1016/j.dld.2012.04.017
URL : https://hal.archives-ouvertes.fr/hal-00942163
The predictive value of treatment response using FDG PET performed on day 21 of chemoradiotherapy in patients with oesophageal squamous cell carcinoma. A prospective, multicentre study (RTEP3), European Journal of Nuclear Medicine and Molecular Imaging, vol.38, issue.7, pp.1345-55, 2013. ,
DOI : 10.1007/s00259-013-2450-7
Pretreatment metabolic tumour volume is predictive of disease-free survival and overall survival in patients with oesophageal squamous cell carcinoma, European Journal of Nuclear Medicine and Molecular Imaging, vol.40, issue.11, p.2014, 2014. ,
DOI : 10.1007/s00259-014-2839-y
URL : https://hal.archives-ouvertes.fr/hal-01120600
Block Matching: A??General??Framework??to??Improve Robustness of??Rigid??Registration of Medical Images, Med. Image Comput. Comput.-Assist ,
DOI : 10.1007/978-3-540-40899-4_57
URL : https://hal.archives-ouvertes.fr/inria-00615860
Available from, pp.557-66978, 1007. ,
Interobserver Agreement of Qualitative Analysis and Tumor Delineation of 18F-Fluoromisonidazole and 3'-Deoxy-3'-18F-Fluorothymidine PET Images in Lung Cancer, Journal of Nuclear Medicine, vol.54, issue.9, pp.1543-50, 2013. ,
DOI : 10.2967/jnumed.112.118083
Pre-Chemoradiation Therapy FDG PET/CT Cannot Identify Residual Metabolically Active Areas in Patients With Locally Advanced Esophageal Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.84, issue.3, p.312, 2012. ,
DOI : 10.1016/j.ijrobp.2012.07.815
Hypoxia and tumor metabolism in radiation oncology: targets visualized by positron emission tomography, Q. J. Nucl. Med. Mol. Imaging Off. Publ. Ital. Assoc. Nucl. Med. AIMN Int. Assoc. Radiopharmacol. IAR Sect. Soc. Radiopharm. Chem. Biol, vol.57, pp.244-56, 2013. ,
Biological significance of 18F-FDG uptake on PET in patients with non-small-cell lung cancer, Lung Cancer, vol.83, issue.2, pp.197-204, 2014. ,
DOI : 10.1016/j.lungcan.2013.11.025
The Warburg Effect: Why and How Do Cancer Cells Activate Glycolysis in the Presence of Oxygen?, Anti-Cancer Agents in Medicinal Chemistry, vol.8, issue.3, pp.305-317, 2008. ,
DOI : 10.2174/187152008783961932
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation, Science, vol.324, issue.5930, pp.1029-1062, 2009. ,
DOI : 10.1126/science.1160809
Why do cancers have high aerobic glycolysis?, Nature Reviews Cancer, vol.62, issue.11, pp.891-900, 2004. ,
DOI : 10.1038/nrc1478
Transcription Factor HIF-1 Is a Necessary Mediator of the Pasteur Effect in Mammalian Cells, Molecular and Cellular Biology, vol.21, issue.10, pp.3436-3480, 2001. ,
DOI : 10.1128/MCB.21.10.3436-3444.2001
Pharmacologic activation of tumor hypoxia: a means to increase tumor 2-deoxy-2-[18F]fluoro-D-glucose uptake?, Mol. Imaging, vol.12, pp.49-58, 2013. ,
The maximum uptake of 18F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1?? and GLUT-1 in non-small cell lung cancer, European Journal of Cancer, vol.43, issue.9, pp.1392-1400, 2007. ,
DOI : 10.1016/j.ejca.2007.03.027
Baseline 18F-FDG PET image-derived parameters for therapy response prediction in oesophageal cancer, European Journal of Nuclear Medicine and Molecular Imaging, vol.17, issue.1, pp.1595-606, 2011. ,
DOI : 10.1007/s00259-011-1834-9
URL : https://hal.archives-ouvertes.fr/inserm-00595534
Prognostic Value of Metabolic Tumor Volume Measured by 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients with Esophageal Carcinoma, Annals of Surgical Oncology, vol.34, issue.1, pp.115-137, 2010. ,
DOI : 10.1245/s10434-009-0719-7
Time-Dose and Tumor Volume Relationships in the Irradiation of Squamous Cell Carcinoma of the Tonsillar Fossa, Radiology, vol.107, issue.3, pp.621-627, 1973. ,
DOI : 10.1148/107.3.621
Monitoring tumour response during chemo-radiotherapy: a parametric method using FDG-PET/CT images in patients with oesophageal cancer, EJNMMI Research, vol.4, issue.1, p.12, 2014. ,
DOI : 10.1186/2191-219X-4-12
URL : https://hal.archives-ouvertes.fr/hal-01141152
Detection and Characterization of Tumor Changes in 18F-FDG PET Patient Monitoring Using Parametric Imaging, Journal of Nuclear Medicine, vol.52, issue.3, pp.354-61, 2011. ,
DOI : 10.2967/jnumed.110.080150
Cone beam CT verification for oesophageal cancer ??? impact of volume selected for image registration, Acta Oncologica, vol.65, issue.2, pp.1183-90, 2011. ,
DOI : 10.1016/j.ijrobp.2006.03.064
18F-Deoxyglucose PET for the staging of oesophageal cancer: influence of histopathological subtype and tumour grading], Nukl. Nucl. Med, vol.42, pp.90-93, 2003. ,
pour l'accueil sympathique dans le service de radiologie et pour m'avoir formé en imagerie cardiaque ,
pour tes connaissances, ta pédagogie, notre case report sur le lymphome osseux et pour m'avoir formé en scintigraphie osseuse ,
Vercellino pour ta gentillesse et nos meetings en province. Pour m'avoir formé en TEP et transmis l'approche « Sherlock Holmes », et donc passionnante ,
pour nos vacations de TEP formatrices et agréables. Nos échanges m'ont beaucoup apporté ,
pour m'avoir formé en TEP et fait partager ton expérience ,
best-chief-ever, pour m'avoir formé en TEP lors de nos vacations-debriefs si cools, le case report Priapisme-FDG, ton humour et ton ,
JEF, véritable guide initiatique, pour tous les conseils d'orientation, l'écoute, le temps et la considération que tu m'as accordés, notamment au début de mon internat. Pour nos posters sur la Choline, nos déjeuners, nos diners, nos pintes de blonde, notamment celle sous 18 F-Choline ,